Literature DB >> 22433345

Uterine synechiae and pregnancy complications.

Methodius G Tuuli1, Anthony Shanks, Lisa Bernhard, Anthony O Odibo, George A Macones, Alison Cahill.   

Abstract

OBJECTIVE: Uterine synechiae have generally been considered benign findings in pregnancy. We used a large perinatal database to test the hypothesis that uterine synechiae are associated with pregnancy complications.
METHODS: We performed a retrospective cohort study of women with singleton pregnancies presenting for routine ultrasonographic examinations at 17-22 weeks from 1990-2009. Pregnancies with multiple fetuses, amniotic bands, and congenital uterine anomalies were excluded. We compared pregnancy outcomes between women with and without uterine synechiae. Multivariable logistic regression was used to adjust for confounders.
RESULTS: Of 65,518 pregnancies meeting inclusion criteria, 296 (0.45%) were diagnosed with uterine synechiae. Women with uterine synechiae were significantly more likely to have placental abruption (2.1% compared with 0.6%, adjusted odds ratio [OR] 3.25, 95% confidence interval [CI] 1.43-7.36), preterm premature rupture of membranes (PROM) (5.5% compared with 2.3%, adjusted OR 2.51, 95% CI 1.51-4.18), and cesarean delivery for malpresentation (5.1% compared with 3.0%, adjusted OR 1.75, 95% CI 1.04-2.95). The risks of placenta previa, fetal growth restriction, stillbirth, and preterm delivery were not significantly different.
CONCLUSION: Uterine synechiae are associated with significant increase in the risk of preterm PROM, placental abruption, and cesarean delivery for malpresentation. The notion of uterine synechiae as benign findings in pregnancy should be re-evaluated. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2012        PMID: 22433345     DOI: 10.1097/AOG.0b013e31824be28a

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Efficient Production of Murine Uterine Damage Model.

Authors:  Yoon Young Kim; Bo Bin Choi; Ji Won Lim; Yong Jin Kim; Sung Yob Kim; Seung-Yup Ku
Journal:  Tissue Eng Regen Med       Date:  2018-08-18       Impact factor: 4.169

2.  CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman's Syndrome.

Authors:  Gulcin Sahin Ersoy; Masoumeh Majidi Zolbin; Emine Cosar; Irene Moridi; Ramanaiah Mamillapalli; Hugh S Taylor
Journal:  Mol Ther Methods Clin Dev       Date:  2017-01-11       Impact factor: 6.698

3.  Preliminary design of a new degradable medical device to prevent the formation and recurrence of intrauterine adhesions.

Authors:  Salome Leprince; Stéphanie Huberlant; Lucie Allegre; Sophie Warembourg; Isabelle Leteuff; Audrey Bethry; Cedric Paniagua; Hubert Taillades; Renaud De Tayrac; Jean Coudane; Vincent Letouzey; Xavier Garric
Journal:  Commun Biol       Date:  2019-05-22

Review 4.  Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome.

Authors:  Silvia Vannuccini; Vicki L Clifton; Ian S Fraser; Hugh S Taylor; Hilary Critchley; Linda C Giudice; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2015-09-22       Impact factor: 15.610

5.  Bone Marrow-Derived Stem Cell (BMDSC) transplantation improves fertility in a murine model of Asherman's syndrome.

Authors:  Feryal Alawadhi; Hongling Du; Hakan Cakmak; Hugh S Taylor
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.